|
ACPE
Advisory Committee on Poliomyelitis Eradication
AD
Auto-disable syringe
AE
Adverse event
AEFI
Adverse event following immunization
AER
Adverse event report
AFP
Acute flaccid paralysis
AFR
WHO African Region
AMR
WHO Region of the
Americas
ARDS
Adult respiratory distress syndrome
aVDPV
Ambiguous vaccine-derived poliovirus
BAG
Biosafety Advisory Group
BSL
Biological safety level
CDC
US Centers for Disease Control and Prevention
CRF
Case report form
cVDPV
Circulating vaccine-derived poliovirus
DSMB
Data safety monitoring board
DTP
Diphtheria-tetanus-pertussis vaccine
EB
Executive Board to the World Health Assembly
ELISA
Enzyme-linked immunosorbent assay
EMR
WHO
Eastern Mediterranean
Region
EPI
Expanded Programme on Immunization
ERC
WHO Research Ethics Review Committee
EUR
WHO European Region
GAPIII
Third edition of the Global Action Plan to minimize post eradication
poliovirus facility-associated risk
GCC
Global Commission for the Certification of the Eradication of
Poliomyelitis
GCP
Good clinical practice
GFIMS Global
Framework for Immunization Monitoring and Surveillance
GIVS
Global Immunization Vision and Strategy
GPEI
Global Polio Eradication Initiative
GPLN
Global Polio Laboratory Network
IB
Investigator's brochure
ICC
Interagency coordinating committee
ICST
Inter-country support team
IEC
Independent ethics committee
IHR (2005)
International Health Regulations (2005)
IPV
Inactivated poliovirus vaccine
IRB
Institutional review board
ITD
Intra-typic differentiation
IV
Intra-venous
IVB
WHO Department of Immunization, Vaccines and Biologicals
IVR
Initiative for Vaccine Research
iVDPV Immunodeficiency-associated vaccine-derived poliovirus
mOPV1 Monovalent
oral poliovirus vaccine type 1
mOPV2 Monovalent
oral poliovirus vaccine type 2
mOPV3 Monovalent
oral poliovirus vaccine type 3
NCC
National Certification Committee
NCL
National control laboratory
NID
National Immunization Day
NPAFP
Non-polio acute flaccid paralysis
NPEV
Non-polio enterovirus
NPSP
National Polio Surveillance Project (
India
)
NRA
National Regulatory Authority
NSL
Non Sabin-like
OPV
Oral poliovirus vaccine
PI
Principal investigator
QA
Quality assurance
QC
Quality control
RCC
Regional Certification Committee
SAE
Severe (or serious) adverse event
SEAR
WHO South-
East Asia
Region
SIA
Supplementary Immunization Activity
sIPV
Sabin IPV
SAGE
Strategic Advisory Group of Experts on Immunization
SL
Sabin-like
SNID
Subnational Immunization Day
SOP
Standard operating procedures
TAG
Technical Advisory Group
tOPV
Trivalent oral poliovirus vaccine
UN
United Nations
UNDP
United Nations Development Programme
UNICEF
United Nations Children's Fund
UTI
Urinary tract infection
VAPP
Vaccine-associated paralytic polio
VDPV
Vaccine-derived poliovirus
VPD
Vaccine-preventable disease
WHA
World Health Assembly
WHO
World Health Organization
WPR
WHO Western Pacific Region
WPV
Wild poliovirus
If you wish to add
acronyms to this list, please send an email to
kahna@who.int.
|
